Clinical Trial Update: Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216) [Phase 3]

View source ↗

Summary

A completed Phase 3 double-blind follow-on safety study of HZT-501 (ibuprofen 800 mg / famotidine 26.6 mg) in participants from prior trials, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome
• Low Back Pain
• Osteoarthritis
• Rheumatoid Arthritis
• Soft Tissue Pain

Drugs mentioned

• Famotidine (famotidine)
• HZT-501
• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Amgen | Conditions: Osteoarthritis, Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-17